Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962894 | Vaccine | 2015 | 6 Pages |
Abstract
A single dose of typhoid Vi polysaccharide vaccine, Typhim Vi®, demonstrated good safety and immunogenicity profile in a Japanese population.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mitsunobu Miyazu, Hitoshi Kikuchi, Atsuo Hamada, Shinji Fukushima, Kazunobu Ouchi, Valerie Bosch Castells, Hanako Mihara, Marie-Claude Bonnet,